Clinical Decision Support Systems Market Report 2026

The clinical decision support systems market size has grown rapidly in recent years. It will grow from $3.51 billion in 2025 to $3.96 billion in 2026 at a compound annual growth rate (CAGR) of 12.9%. The growth in the historic period can be attributed to increasing adoption of electronic health records, rising clinical data complexity, growing emphasis on evidence-based medicine, expansion of digital hospital infrastructure, early adoption of rule-based decision systems.

The clinical decision support systems market size is expected to see rapid growth in the next few years. It will grow to $6.49 billion in 2030 at a compound annual growth rate (CAGR) of 13.1%. The growth in the forecast period can be attributed to increasing demand for personalized clinical decision-making, rising investments in ai-enabled healthcare solutions, expansion of remote and virtual care models, growing focus on reducing diagnostic errors, increased integration with population health platforms. Major trends in the forecast period include increasing integration of AI-driven clinical recommendations, rising deployment of ehr-integrated cdss solutions, growing use of predictive analytics in care decisions, expansion of cloud-based decision support platforms, enhanced focus on real-time clinical alerts.

The increasing demand for cloud computing is expected to drive the growth of the clinical decision support systems market in the coming years. Cloud computing is a technology that enables the delivery of computing services over the internet, allowing organizations and individuals to access, manage, and scale hardware and software resources without maintaining physical infrastructure. In clinical decision support systems, cloud computing enables healthcare organizations to store and manage large volumes of patient data, medical records, and related information on centralized cloud servers. For instance, in 2025, according to Eurostat, a Luxembourg-based statistical office of the European Union, 45% of EU businesses purchased cloud computing services in 2023. Adoption was notably higher among large enterprises, with 78% using cloud services compared to 44% of small and medium-sized enterprises. Therefore, the growing adoption of cloud computing is contributing to the expansion of the clinical decision support systems market.

Major companies operating in the clinical decision support systems market are focusing on the development and launch of advanced solutions such as insulin dosing software to strengthen their competitive position. Insulin dosing software consists of specialized clinical decision support tools that assist healthcare providers in determining and administering appropriate insulin doses, supporting personalized and safe glycemic control. For example, in April 2023, Glytec, a US-based platform provider, launched an updated version of its Glucommander insulin dosing platform. Glucommander is a cloud-based solution designed to deliver personalized intravenous and subcutaneous insulin dosing for patients, regardless of diabetes status. The platform integrates with electronic health record systems to streamline clinical workflows and enhance patient safety in insulin management.

In October 2024, VitalHub Corp., a US-based healthcare technology company, acquired MedCurrent Corporation for an undisclosed amount. This acquisition supports VitalHub’s strategy of expanding its portfolio through the integration of advanced healthcare technology solutions aimed at improving care delivery. MedCurrent Corporation is a US-based healthcare technology company specializing in clinical decision support solutions.

Major companies operating in the clinical decision support systems market are McKesson Corporation, Siemens Healthineers AG, Koninklijke Philips N.V., GE Healthcare, Hera-MI LLC, Cerner Corporation, Epic Systems Corporation, Elsevier B.V., Change Healthcare Corporation, Allscripts Healthcare Solutions Inc., Athenahealth Inc., Wolters Kluwer Health, Premier Inc., eClinicalWorks Inc., Veradigm Inc., NextGen Healthcare Inc., Medical Information Technology Inc., Meditech Systems Network Inc., Health Catalyst, CareCloud Inc., CureMD Inc., Strata Decision Technology, Zynx Health, First Databank Inc., Clinical Architecture Inc., VisualDx Group Inc., Apervita Inc., IBM Watson Health, The Medical Algorithms Company LP, RAMPmedical Inc.

North America was the largest region in the clinical decision support systems market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the clinical decision support systems market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the clinical decision support systems market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are impacting the clinical decision support systems market by increasing costs of imported servers, data processing hardware, networking equipment, and advanced analytics software used in CDSS deployments. Healthcare providers in North America and Europe are most affected due to reliance on imported IT infrastructure, while Asia-Pacific faces higher costs for system integration and deployment. These tariffs are raising implementation expenses and slowing digital health upgrades. However, they are also driving adoption of cloud-based CDSS solutions, regional software development, and localized hosting strategies that reduce long-term dependency on imported hardware.

The clinical decision support systems market research report is one of a series of new reports that provides clinical decision support systems market statistics, including clinical decision support systems industry global market size, regional shares, competitors with a clinical decision support systems market share, detailed clinical decision support systems market segments, market trends and opportunities, and any further data you may need to thrive in the clinical decision support systems industry. This clinical decision support systems market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Clinical decision support systems (CDSS) are computer-based applications that analyze data from electronic health records to provide healthcare professionals with alerts, reminders, and recommendations at the point of care, supporting the implementation of evidence-based clinical guidelines.

The primary components of clinical decision support systems include services, software, and hardware. CDSS models include knowledge-based and non-knowledge-based systems and are delivered through various deployment modes such as on-premise and cloud-based. On-premise CDSS solutions are deployed within an organization’s internal IT infrastructure. On-premise clinical decision support software is installed and operated on local computers within a facility. These systems are used for applications such as medical diagnosis, alerts and reminders, prescription decision support, information retrieval, and other functions across healthcare settings including clinics, hospitals, ambulatory surgical centers, and other end users.

The clinical decision support systems (CDSS) market consists of sales of knowledge based CDSS, and non knowledge-based CDSS. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.